Ignite Creation Date:
2025-12-26 @ 1:17 PM
Ignite Modification Date:
2025-12-31 @ 8:37 PM
Study NCT ID:
NCT04008706
Status:
COMPLETED
Last Update Posted:
2025-12-01
First Post:
2019-06-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Acalabrutinib Safety Study in Untreated and Relapsed or Refractory Chronic Lymphocytic Leukemia Patients
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-17
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-11-04
Completion Date Type:
ACTUAL
First Submit Date:
2019-06-19
First Submit QC Date:
None
Study First Post Date:
2019-07-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-28
Last Update Post Date:
2025-12-01
Last Update Post Date Type:
ESTIMATED